These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7474392)

  • 21. Clinical hemostasis practice: the major impact of laboratory automation.
    Bick RL
    Semin Thromb Hemost; 1983 Jul; 9(3):139-71. PubMed ID: 6412362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombosis and fibrinolysis].
    Tanaka K
    Rinsho Byori; 1969; 16():Suppl 16:10+. PubMed ID: 4903819
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation and diagnostic efficacy of synthetic-substrate methods for coagulation and fibrinolytic factors].
    Asai K; Asai M
    Rinsho Byori; 1987 Feb; 35(2):147-59. PubMed ID: 3295327
    [No Abstract]   [Full Text] [Related]  

  • 24. [Blood coagulating and fibrinolytic factors of the lung tissue and their role in the pathogenesis of afibrinogenemic hemorrhages].
    Ruseĭkin NS
    Probl Gematol Pereliv Krovi; 1972 Sep; 17(9):17-21. PubMed ID: 4668371
    [No Abstract]   [Full Text] [Related]  

  • 25. Automation and quality control in the coagulation laboratory.
    Walenga JM; Fareed J
    Clin Lab Med; 1994 Dec; 14(4):709-28. PubMed ID: 7874868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New assay methods on blood clotting and fibrinolytic factors (author's transl)].
    Fujimaki M
    Rinsho Byori; 1982 Jan; 30(1):44-53. PubMed ID: 7087230
    [No Abstract]   [Full Text] [Related]  

  • 27. Migratory venous thrombosis and cancer: mechanisms and clinical manifestations.
    Nusbacher J
    Prog Clin Cancer; 1967; 3():151-6. PubMed ID: 4867088
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF.
    Bellucci S; Ignatova E; Jaillet N; Boffa MC
    Thromb Haemost; 1993 Nov; 70(5):736-42. PubMed ID: 8128427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a rapid assay as an alternative to conventional enzyme immunoassays for detection of hepatitis C virus-specific antibodies.
    Daniel HD; Abraham P; Raghuraman S; Vivekanandan P; Subramaniam T; Sridharan G
    J Clin Microbiol; 2005 Apr; 43(4):1977-8. PubMed ID: 15815036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoassays for diagnosis of coagulation disorders.
    Kappel A; Ehm M
    Hamostaseologie; 2010 Nov; 30(4):194-201. PubMed ID: 21057714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New possibilities for quantitative determination of blood clotting and fibrinolytic factors].
    Ivanov V; Shipkov T
    Vutr Boles; 1982; 21(6):7-13. PubMed ID: 6761966
    [No Abstract]   [Full Text] [Related]  

  • 33. Coagulation factors and components of the fibrinolytic system in lymph and blood in dogs.
    Leandoer L; Bergentz SE; Nilsson IM
    Thromb Diath Haemorrh; 1968 Mar; 19(1):129-35. PubMed ID: 5652223
    [No Abstract]   [Full Text] [Related]  

  • 34. [Various problems of the diagnosis of coagulation disorders of fibrinolytic and consumption coagulopathy].
    Dyk T
    Pol Tyg Lek; 1969 Mar; 24(12):451-4. PubMed ID: 4892176
    [No Abstract]   [Full Text] [Related]  

  • 35. Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis.
    Ieko M; Nakabayashi T; Tarumi T; Naito S; Yoshida M; Kanazawa K; Mizukami K; Koike T
    Clin Chim Acta; 2007; 386(1-2):38-45. PubMed ID: 17803984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical hemorrhagic syndrome. Elaboration of a practical procedure of investigation and treatment in the absence of a specialized laboratory].
    Otteni JC; Boyer C; Girardel JM; Gauthier-Lafaye JP
    Anesth Analg (Paris); 1969; 26(1):89-106. PubMed ID: 5793321
    [No Abstract]   [Full Text] [Related]  

  • 38. Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever).
    Lee M; Kim BK; Kim S; Park S; Han JS; Kim ST; Lee JS
    Rev Infect Dis; 1989; 11 Suppl 4():S877-83. PubMed ID: 2568677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of immunologic assays to the coagulation laboratory.
    Brown GD
    Clin Lab Med; 1984 Jun; 4(2):345-61. PubMed ID: 6437736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.